Medication management for people with dementia in primary care: description of implementation in the DelpHi study

详细信息    查看全文

• 作者：Thomas Fi? (1)
  Jochen René Thyrian (1) (2)
  Diana Wucherer (1)
  Grit A?mann (1)
  Ingo Kilimann (1) (3)
  Stefan J Teipel (1) (3)
  Wolfgang Hoffmann (1) (2)
  
• 关键词：Home medication review ; Drug related problems ; Dementia ; Potentially inappropriate medication ; Health services research
• 刊名：BMC Geriatrics
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：13
• 期：1
• 全文大小：209 KB
• 参考文献：1. Siewert U, Fendrich K, Doblhammer-Reiter G, Scholz RD, Schuff-Werner P, Hoffmann W: Health care consequences of demographic changes in Mecklenburg-West Pomerania: projected case numbers for age-related diseases up to the year 2020, based on the study of health in Pomerania (SHIP). / Dtsch Arztebl Int 2010, 107:328-34.
  2. Thyrian JR, Dreier A, Fendrich K, Lueke S, Hoffmann W: Demenzerkrankungen–Wirksame Konzepte gesucht. / Deutsches ?rzteblatt 2011, 108:A1954-A1956.
  3. National Institute for Health and Clinical Excellence: / NICE clinical guideline. 42nd edition. NICE; 2006. [ / Dementia supporting people with dementia and their carers in health and social care] http://publications.nice.org.uk/dementia-cg42
  4. Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, / et al.: The cognitive impact of anticholinergics: a clinical review. / Clin Interv Aging 2009, 4:225-33.
  5. Fortin MP, Rouch I, Dauphinot V, Gedeon C, Genthon S, Bonnefoy M, / et al.: Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study. / Drugs Aging 2011, 28:195-04. CrossRef
  6. Sela-Katz P, Rabinowitz I, Shugaev I, Shigorina G: Basic knowledge of the medication regimen correlates with performance on cognitive function tests and diagnosis of dementia in elderly patients referred to a geriatric assessment unit. / Gerontology 2010, 56:491-95. CrossRef
  7. Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Salje K, Mueller S, / et al.: Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. / Pharmacoepidemiol Drug Saf 2011, 20:626-34. CrossRef
  8. Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. / Eur J Clin Pharmacol 2002, 58:285-91. CrossRef
  9. Schaefer M: Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. / Pharm World Sci 2002, 24:120-27. CrossRef
  10. Cancelli I, Beltrame M, Gigli GL, Valente M: Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. / Neurol Sci 2009, 30:87-2. CrossRef
  11. Cancelli I, Beltrame M, D’Anna L, Gigli GL, Valente M: Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer’s disease? / Expert Opin Drug Saf 2009, 8:549-57. CrossRef
  12. Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, / et al.: Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. / Arch Intern Med 2009, 169:1317-324. CrossRef
  13. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J: The appropriateness of drug use in an older nondemented and demented population. / J Am Geriatr Soc 2001, 49:277-83. CrossRef
  14. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ: Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. / Br J Clin Pharmacol 2007, 63:232-37. CrossRef
  15. Hoffmann W, van den Berg N, Thyrian JR, Fiss T: Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs–results of the home medication review in the AGnES-studies. / Pharmacoepidemiol Drug Saf 2011,20(12):1311-318. CrossRef
  16. Arlt S, Lindner R, Rosler A, Von Renteln-Kruse W: Adherence to medication in patients with dementia: predictors and strategies for improvement. / Drugs Aging 2008, 25:1033-047. CrossRef
  17. Jackson SH, Jansen PA, Mangoni AA: Off-label prescribing in older patients. / Drugs Aging 2012, 29:427-34. CrossRef
  18. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, / et al.: Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. / BMJ 2005, 330:293. CrossRef
  19. Holland R, Smith R, Harvey I: Where now for pharmacist led medication review? / J Epidemiol Community Health 2006, 60:92-3. CrossRef
  20. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK: Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. / Br J Clin Pharmacol 2008, 65:303-16. CrossRef
  21. Schaefer M, Schulz M, Emmermann A, Mühlbauer K, Verheyen F: / Manuale zur Pharmazeutischen Betreuung-Band 1: Grundlagen der Pharmazeutischen Betreuung [manual fo pharmaceutical care: part I: basics]. ABDA-Bundesvereinigung Deutscher Apotheker GOVI-Verlag Eschborn; 2000.
  22. Fiss T: / Erfassung und L?sung arzneimittelbezogener Probleme in einer Kohorte ?lterer, multimorbider Hausbesuchspatienten. Hamburg: Verlag Dr. Kovac GmbH; 2011. Eschborn preceding to the year 2000
  23. Maidment ID, Fox C, Boustani M, Katona C: Medication management-the missing link in dementia interventions. / Circulation 2006,114(13):1432-445. CrossRef
  24. Krumholz HM, Currie PM, Riegel B, Phillips CO, Peterson ED, Smith R, / et al.: A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. / Circulation 2006, 114:1432-445. CrossRef
  25. Eickhoff C, Schulz M: Pharmaceutical care in community pharmacies: practice and research in Germany. / Ann Pharmacother 2006, 40:729-35. CrossRef
  26. Karopka T, Bruder I, van den Berg N, Hoffmann W, Heuer A: ICT architecture for a community medicine nurse project. / Healthinf 2008: Proc First Int Conf Health Inform 2008, 2:26-0.
  27. Thyrian JR, Fiss T, Dreier A, Bowing G, Angelow A, Lueke S, / et al.: Life-and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): study protocol for a randomised controlled trial. / Trials 2012, 13:56. CrossRef
  28. Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, / et al.: DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. / Int J Geriatr Psychiatry 2004, 19:136-43. CrossRef
  29. Dreier A, Thyrian JR, Hoffmann W: Dementia care manager in der ambulanten Demenzversorgung: Entwicklung einer innovativen Qualifizierung für Pflegefachkr?fte. / Pflege&Gesellschaft 2011, 16:53-4.
  30. Sandholzer H, Hellenbrand W, Renteln-Kruse W, Van WC, Walker P: STEP–standardized assessment of elderly people in primary care. / Dtsch Med Wochenschr 2004,129(Suppl 4):S183-S226. CrossRef
  31. Zaudig M: A new systematic method of measurement and diagnosis of “mild cognitive impairment-and dementia according to ICD-10 and DSM-III-R criteria. / Int Psychogeriatr 1992,4(Suppl 2):203-19. CrossRef
  32. Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W: Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. / Pharm World Sci 2010, 32:566-76. CrossRef
  33. de KE, Van der HD, Landewe R, Van der TH, Van der LS: The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. / J Rheumatol 2003, 30:2469-475.
  34. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. / Med Care 1986, 24:67-4. CrossRef
  35. Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. / Schizophr Res 2000, 42:241-47. CrossRef
  36. Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE: The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. / Pharm World Sci 2009,31(4):426-31. CrossRef
  37. Meyer J, Ostrzinski S, Fredrich D, Havemann C, Krafczyk J, Hoffmann W: Efficient data management in a large-scale epidemiology research project. / Comput Methods Programs Biomed 2012, 107:425-35. CrossRef
  38. Hansten PD, Horn JR, Hazlet TK: ORCA: OpeRational classificAtion of drug interactions. / J Am Pharm Assoc (Wash ) 2001, 41:161-65.
  39. Vonbach P, Dubied A, Krahenbuhl S, Beer JH: Evaluation of frequently used drug interaction screening programs. / Pharm World Sci 2008, 30:367-74. CrossRef
  40. ABDATA Pharma-Daten Service: / ABDA-Datenbank [ABDA database]. 2010. http://www.wuv-gmbh.de/abdata.html
  41. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. / Arch Intern Med 1991, 151:1825-832. CrossRef
  42. Chien WT, Lee IY: Randomized controlled trial of a dementia care programme for families of home-resided older people with dementia. / J Adv Nurs 2010,67(4):774-7. CrossRef
  43. Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J: Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. / Am J Geriatr Pharmacother 2005, 3:246-54. CrossRef
  44. Geurts MM, Talsma J, Brouwers JR, De Gier JJ: Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. / Br J Clin Pharmacol 2012.
  45. Topinkova E, Baeyens JP, Michel JP, Lang PO: Evidence-based strategies for the optimization of pharmacotherapy in older people. / Drugs Aging 2012, 29:477-94. CrossRef
  46. Schaefer M: Systematic drug documentation. / Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005, 48:736-41. CrossRef
  47. Spinewine A, Fialova D, Byrne S: The role of the pharmacist in optimizing pharmacotherapy in older people. / Drugs Aging 2012, 29:495-10. CrossRef
  48. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2318/13/121/prepub
  
• 作者单位：Thomas Fi? (1)
  Jochen René Thyrian (1) (2)
  Diana Wucherer (1)
  Grit A?mann (1)
  Ingo Kilimann (1) (3)
  Stefan J Teipel (1) (3)
  Wolfgang Hoffmann (1) (2)
  
  1. German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany
  2. Institute for Community Medicine, University of Greifswald, Ellernholzstr 1-2, 17489, Greifswald, Germany
  3. Department of Psychosomatic Medicine, University Hospital Rostock, Gehlsheimer Stra?e 28, 18147, Rostock, Germany
  
• ISSN：1471-2318

文摘

Background As the population ages, the relative and absolute number of age-associated diseases such as dementia will increase. Evaluation of the suitability and intake of medication and pharmacological treatment is an important aspect of care for people with dementia, especially if they live at home. Regular medication reviews and systematic cooperation between physicians and pharmacists are not common in routine care. Medication management (MM), based on such a comprehensive home medication review could help to reduce drug-related problems and costs. The present article presents a medication management specifically for the application in the ambulatory setting and describes its implementation as part of a larger trial. Methods/design A home medication review (HMR) and MM is implemented as part of the DelpHi study, a population based prospective, cluster-randomized controlled intervention study to test the efficacy and efficiency of the implementation of a collaborative care model in primary care. Participants: people with dementia (PWD) and their caregivers are recruited by the patient’s general practitioner. Inclusion criteria are a positive screening result for dementia, living at home and regular intake of drugs. PWD are asked to specify their regular pharmacy which is asked to participate in the study, too. Intervention: a comprehensive HMR is conducted as computer-assisted personal interview by specifically qualified Dementia Care Manager (DCM) at the people’s home. It includes detailed information about drugs taken, their storage, administration, adherence and adverse events. The MM is conducted in cooperation between DCM, pharmacist and general practitioner and consists of a pharmaceutical evaluation, pharmaceutical recommendations and their application. Pharmacists are trained and provided with regularly updated information. The MM is designed to give information and recommendations concerning antidementia drugs, occurrence of drug related problems, intake of anticholinergic drugs, potentially clinically relevant drug-drug-interactions, adverse drug events and medication adherence. Discussion The DelpHi-approach for medication management employs comprehensive instruments and procedures in the primary care setting under routine care conditions, and this approach should be useful in improving pharmacotherapy as part of the comprehensive treatment and care for people with dementia. Trial registration The trial is registered at ClinicalTrials.gov, number NCT01401582.